Share price: 105.00p

Director/PDMR Shareholding

19th September 2013

Cello Group plc (“Cello” or the “Company”)

Director’s dealing

The Company has been notified that on 18th September 2013 Mark Scott, the Chief Executive of the Company, purchased 15,200 ordinary shares of 10 pence each in the Company (“Ordinary Shares”). The purchase price was 64.04 pence per Ordinary Share. Mr Scott also notified the Company that on 18th September 2013 he transferred 15,200 Ordinary Shares from his own name into his SIPP. The transfer price was 63.50 pence. The transfer has no effect on the total number of Ordinary Shares held by Mr Scott.

Following the purchase, Mr Scott is beneficially and non-beneficially interested in 921,069 Ordinary Shares, representing 1.1 per cent. of the current issued share capital of the Company.

19th September 2013

Enquiries:

 

Cello Group                                    020 7812 8460
Mark Bentley, Finance Director

 

Cenkos Securities                          020 7397 8900
Bobbie Hilliam

 

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150